53 results
8-K
EX-2.1
RVLPQ
RVL Pharmaceuticals plc
27 Nov 23
Bankruptcy or Receivership
4:06pm
separate Class. Class Claims or Interests Status Voting Rights 1 Other Secured Claims Unimpaired Not Entitled to Vote (Conclusively Presumed to Accept … Claims or Interests Status Voting Rights 7 Equity Interests Unimpaired/ Impaired Not Entitled to Vote (Conclusively Presumed to Accept or Deemed
8-K
EX-99.1
RVLPQ
RVL Pharmaceuticals plc
13 Oct 23
Termination of a Material Definitive Agreement
4:15pm
Status
Voting Rights
Other Secured Claims
Unimpaired
Not Entitled to Vote (Conclusively Presumed to Accept)
Priority Non-Tax Claims
Unimpaired
8-K
EX-4.2
RVLPQ
RVL Pharmaceuticals plc
18 Aug 23
RVL Pharmaceuticals plc Announces $5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
4:06pm
voting rights, dividends or other rights as a shareholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except
8-K
EX-4.4
l54r7r
18 Aug 23
RVL Pharmaceuticals plc Announces $5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
4:06pm
8-K
EX-4.1
lflzh37y
18 Aug 23
RVL Pharmaceuticals plc Announces $5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
4:06pm
8-K
EX-4.3
62rq1y9pqc
18 Aug 23
RVL Pharmaceuticals plc Announces $5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
4:06pm
424B5
305ul
17 Aug 23
Prospectus supplement for primary offering
4:05pm
8-K
EX-3.1
e0zg7om
18 Jan 22
Amendments to Articles of Incorporation or Bylaws
8:16am
8-K
EX-4.1
jmul2tvwpratackja
12 Oct 21
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
4:46pm
424B5
bwypx7vkl
8 Oct 21
Prospectus supplement for primary offering
5:13pm